Guizhou Sanli Pharmaceutical Co Ltd (603439) — Capital Reinvestment Ratio
Guizhou Sanli Pharmaceutical Co Ltd (603439) has a Capital Reinvestment Ratio of 0.22x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥33.19 Million) in capital expenditures (CN¥7.40 Million). Check Guizhou Sanli Pharmaceutical Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guizhou Sanli Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Guizhou Sanli Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Guizhou Sanli Pharmaceutical Co Ltd.
Annual Capital Reinvestment Ratio for Guizhou Sanli Pharmaceutical Co Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Guizhou Sanli Pharmaceutical Co Ltd from 2013 to 2024. See 603439 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.42x | CN¥107.07 Million | CN¥45.20 Million | ▲ +7.4% |
| 2023 | 0.39x | CN¥276.70 Million | CN¥108.73 Million | ▼ -3.9% |
| 2022 | 0.41x | CN¥293.29 Million | CN¥119.91 Million | ▲ +143.1% |
| 2021 | 0.17x | CN¥155.04 Million | CN¥26.08 Million | ▼ -79.4% |
| 2020 | 0.82x | CN¥63.25 Million | CN¥51.71 Million | ▲ +1086.3% |
| 2019 | 0.07x | CN¥116.24 Million | CN¥8.01 Million | ▲ +190.9% |
| 2018 | 0.02x | CN¥75.35 Million | CN¥1.78 Million | ▼ -81.0% |
| 2017 | 0.12x | CN¥57.47 Million | CN¥7.17 Million | ▼ -64.6% |
| 2016 | 0.35x | CN¥35.10 Million | CN¥12.36 Million | ▼ -76.8% |
| 2015 | 1.52x | CN¥33.28 Million | CN¥50.53 Million | ▼ -96.7% |
| 2014 | 46.66x | CN¥563.46K | CN¥26.29 Million | ▲ +15913.9% |
| 2013 | 0.29x | CN¥30.09 Million | CN¥8.77 Million | — |